Cite
HARVARD Citation
Normanno, N. et al. (2018). RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial. Annals of oncology. pp. 112-118. [Online].